Ashwani Gujral of ashwanigujral.com told CNBC-TV18, "Granules India has good risk reward in the sense that it has not really rallied. The stock has made a base. So, you could get Rs 135-140 on Granules India. But, obviously, there are better stocks in midcap pharmaceutical space.""Just Dial is just about crossing its 200-day moving average and facing some resistance out there. It appears like we will see Rs 950 on the stock. So, on declines, Just Dial is a fairly decent buy," he said."Tata Steel has seen profit booking, but it is still trading at the highs of the day. So, the gap down has been bought. Tata Steel remains a buy on dips type of story. You will finally see Rs 350-360 coming on the stock," he added.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!